126 related articles for article (PubMed ID: 36000451)
1. Murine diabetic models for dengue virus infection.
Liu X; Liu Y; Wu H; He Z; Li Z; Qin Z; Yu J; Zhu L; Wu Q; Xiao W; Shen C; Wan C; Zhang B; Zhao W
J Med Virol; 2022 Dec; 94(12):5943-5953. PubMed ID: 36000451
[TBL] [Abstract][Full Text] [Related]
2. A murine model of dengue virus infection in suckling C57BL/6 and BALB/c mice.
Byrne AB; García AG; Brahamian JM; Mauri A; Ferretti A; Polack FP; Talarico LB
Animal Model Exp Med; 2021 Mar; 4(1):16-26. PubMed ID: 33738433
[TBL] [Abstract][Full Text] [Related]
3. Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.
Frias-Staheli N; Dorner M; Marukian S; Billerbeck E; Labitt RN; Rice CM; Ploss A
J Virol; 2014 Feb; 88(4):2205-18. PubMed ID: 24335303
[TBL] [Abstract][Full Text] [Related]
4. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
5. Animal models of dengue virus infection.
Zompi S; Harris E
Viruses; 2012 Jan; 4(1):62-82. PubMed ID: 22355452
[TBL] [Abstract][Full Text] [Related]
6. Immunocompetent mice model for dengue virus infection [corrected].
Gonçalves D; de Queiroz Prado R; Almeida Xavier E; Cristina de Oliveira N; da Matta Guedes PM; da Silva JS; Moraes Figueiredo LT; Aquino VH
ScientificWorldJournal; 2012; 2012():525947. PubMed ID: 22666132
[TBL] [Abstract][Full Text] [Related]
7. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
8. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
9. Morphological Aspects and Viremia Analysis of BALB/c Murine Model Experimentally Infected with Dengue Virus Serotype 4.
da Costa Rasinhas A; Cunha Jácome F; Cardoso Caldas G; Teixeira de Almeida AL; Nunes da Silva MA; Dias Coutinho de Souza D; Carlos Paulino A; Mendes Bandeira D; Leonardo R; Conrado Guerra Nunes P; Mohana-Borges R; Monika Barth O; Barreto Dos Santos F; Ferreira Barreto Vieira D
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696384
[TBL] [Abstract][Full Text] [Related]
10. Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model.
Barros VE; dos Santos-Junior NN; Amarilla AA; Soares AM; Lourencini R; Trabuco AC; Aquino VH
BMC Microbiol; 2015 Sep; 15():189. PubMed ID: 26415508
[TBL] [Abstract][Full Text] [Related]
11. Murine models of dengue virus infection for novel drug discovery.
Byrne AB; García CC; Damonte EB; Talarico LB
Expert Opin Drug Discov; 2022 Apr; 17(4):397-412. PubMed ID: 35098849
[TBL] [Abstract][Full Text] [Related]
12. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
[TBL] [Abstract][Full Text] [Related]
13. Callithrix penicillata: a feasible experimental model for dengue virus infection.
Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
[TBL] [Abstract][Full Text] [Related]
14. Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from a Single Clinical Viral Isolate.
Zheng Z; Li M; Liu Z; Jin X; Sun J
Virol Sin; 2020 Oct; 35(5):626-636. PubMed ID: 32451883
[TBL] [Abstract][Full Text] [Related]
15. Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice.
Pan P; Zhang Q; Liu W; Wang W; Lao Z; Zhang W; Shen M; Wan P; Xiao F; Liu F; Zhang W; Tan Q; Liu X; Wu K; Liu Y; Li G; Wu J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413130
[TBL] [Abstract][Full Text] [Related]
16. An adenosine nucleoside inhibitor of dengue virus.
Yin Z; Chen YL; Schul W; Wang QY; Gu F; Duraiswamy J; Kondreddi RR; Niyomrattanakit P; Lakshminarayana SB; Goh A; Xu HY; Liu W; Liu B; Lim JY; Ng CY; Qing M; Lim CC; Yip A; Wang G; Chan WL; Tan HP; Lin K; Zhang B; Zou G; Bernard KA; Garrett C; Beltz K; Dong M; Weaver M; He H; Pichota A; Dartois V; Keller TH; Shi PY
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20435-9. PubMed ID: 19918064
[TBL] [Abstract][Full Text] [Related]
17. A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infection.
Costa VV; Fagundes CT; Valadão DF; Cisalpino D; Dias AC; Silveira KD; Kangussu LM; Ávila TV; Bonfim MR; Bonaventura D; Silva TA; Sousa LP; Rachid MA; Vieira LQ; Menezes GB; de Paula AM; Atrasheuskaya A; Ignatyev G; Teixeira MM; Souza DG
PLoS Negl Trop Dis; 2012; 6(5):e1663. PubMed ID: 22666512
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys.
Farias KJ; Machado PR; Muniz JA; Imbeloni AA; da Fonseca BA
Viral Immunol; 2015 Apr; 28(3):161-9. PubMed ID: 25664975
[TBL] [Abstract][Full Text] [Related]
19. Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4.
Barban V; Mantel N; De Montfort A; Pagnon A; Pradezynski F; Lang J; Boudet F
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593041
[TBL] [Abstract][Full Text] [Related]
20. Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice.
Costa VV; Fagundes CT; Valadão DF; Ávila TV; Cisalpino D; Rocha RF; Ribeiro LS; Ascenção FR; Kangussu LM; Celso MQ; Astigarraga RG; Gouveia FL; Silva TA; Bonaventura D; Sampaio Dde A; Leite AC; Teixeira MM; Souza DG
Med Microbiol Immunol; 2014 Aug; 203(4):231-50. PubMed ID: 24723052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
